Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Subtenon injection of natural leukocyte interferon α-2a in diabetic macular edema: a case report.

Cellini M, Balducci N, Strobbe E, Campos EC.

BMC Ophthalmol. 2013 Oct 28;13:63. doi: 10.1186/1471-2415-13-63.

2.

Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes.

Jew OM, Peyman M, Chen TC, Visvaraja S.

Int J Ophthalmol. 2012;5(4):499-504. doi: 10.3980/j.issn.2222-3959.2012.04.18.

3.

Diabetic macular edema: current and emerging therapies.

Wenick AS, Bressler NM.

Middle East Afr J Ophthalmol. 2012 Jan;19(1):4-12. doi: 10.4103/0974-9233.92110.

4.

Novel rodent models for macular research.

Huber G, Heynen S, Imsand C, vom Hagen F, Muehlfriedel R, Tanimoto N, Feng Y, Hammes HP, Grimm C, Peichl L, Seeliger MW, Beck SC.

PLoS One. 2010 Oct 15;5(10):e13403. doi: 10.1371/journal.pone.0013403.

5.

Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Chiu CJ, Taylor A.

Prog Retin Eye Res. 2011 Jan;30(1):18-53. doi: 10.1016/j.preteyeres.2010.09.001. Review.

6.

Comparison of serum glycosylated hemoglobin levels in patients with diabetic cystoid macular edema with and without serous macular detachment.

Turgut B, Gul FC, Ilhan N, Demir T, Celiker U.

Indian J Ophthalmol. 2010 Sep-Oct;58(5):381-4. doi: 10.4103/0301-4738.67044.

Items per page

Supplemental Content

Support Center